SCHEMBL1717655

SCHEMBL1717655

CC(COCC(F)(F)F)OCC(F)(F)F

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.33
PLA2G2C Q5R387 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29531778 0.81
SCHEMBL126785 0.77 PLA2G2C (0.35) PLA2G2C
SCHEMBL9937236 0.76 HTT (0.36) PLA2G2C
SCHEMBL9937945 0.76 HTT (0.36) TDP1PLA2G2C
SCHEMBL27475836 0.75 MEN1 (0.36)
SCHEMBL108185 0.75 MEN1 (0.36)
SCHEMBL21066949 0.75 PLA2G2C (0.34) PLA2G2C
SCHEMBL20762321 0.75 MEN1 (0.36)
SCHEMBL9874884 0.74
SCHEMBL15383221 0.73 TDP1 (0.34) TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 161 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12407022-B2 Electrolyte and electrochemical device NINGDE AMPEREX TECHNOLOGY LIMITED (CN) 2025-09-02 US claimed
US-12240798-B2 Electrolyte, and electrochemical device and electronic device including same NINGDE AMPEREX TECHNOLOGY LIMITED (CN) 2025-03-04 US claimed
US-20250062410-A1 ELECTROLYTE AND ELECTROCHEMICAL DEVICE NINGDE AMPEREX TECHNOLOGY LIMITED (CN) 2025-02-20 US claimed
US-20250062409-A1 ELECTROLYTE AND ELECTROCHEMICAL DEVICE NINGDE AMPEREX TECHNOLOGY LIMITED (CN) 2025-02-20 US claimed
US-20250062408-A1 ELECTROLYTE AND ELECTROCHEMICAL DEVICE NINGDE AMPEREX TECHNOLOGY LIMITED (CN) 2025-02-20 US claimed
US-12183884-B2 Electrolyte and electrochemical device NINGDE AMPEREX TECHNOLOGY LIMITED (CN) 2024-12-31 US claimed
US-12176487-B2 Electrolyte and electrochemical device NINGDE AMPEREX TECHNOLOGY LIMITED (CN) 2024-12-24 US claimed
US-12176486-B2 Electrolyte and electrochemical device NINGDE AMPEREX TECHNOLOGY LIMITED (CN) 2024-12-24 US claimed
EP-3907801-B1 ELECTROLYTE AND ELECTROCHEMICAL DEVICE NINGDE AMPEREX TECHNOLOGY LTD (CN) 2024-11-13 EP claimed
CN-114223080-B Electrolyte, electrochemical device, and electronic device 宁德新能源科技有限公司 2024-10-29 CN claimed
EP-4235900-A2 ELECTROLYTE AND ELECTROCHEMICAL DEVICE Ningde Amperex Technology Ltd. (CN) 2023-08-30 EP claimed
EP-3910714-B1 ELECTROLYTE AND ELECTROCHEMICAL DEVICE NINGDE AMPEREX TECHNOLOGY LTD (CN) 2023-08-09 EP claimed
US-20230128988-A1 ELECTROLYTE AND ELECTROCHEMICAL DEVICE NINGDE AMPEREX TECHNOLOGY LIMITED (CN) 2023-04-27 US claimed
US-20230102805-A1 ELECTROLYTE AND ELECTROCHEMICAL DEVICE NINGDE AMPEREX TECHNOLOGY LIMITED (CN) 2023-03-30 US claimed
US-20220407108-A1 ELECTROLYTE AND ELECTROCHEMICAL DEVICE NINGDE AMPEREX TECHNOLOGY LIMITED (CN) 2022-12-22 US claimed
US-20220407109-A1 ELECTROLYTE AND ELECTROCHEMICAL DEVICE NINGDE AMPEREX TECHNOLOGY LIMITED (CN) 2022-12-22 US claimed
US-11527776-B2 Electrolyte and electrochemical device NINGDE AMPEREX TECHNOLOGY LIMITED (CN) 2022-12-13 US claimed
US-11444330-B2 Electrolytic solution and electrochemical device using the same NINGDE AMPEREX TECHNOLOGY LIMITED (CN) 2022-09-13 US claimed
US-20220153690-A1 ELECTROLYTE, AND ELECTROCHEMICAL DEVICE AND ELECTRONIC DEVICE INCLUDING SAME NINGDE AMPEREX TECHNOLOGY LIMITED (CN) 2022-05-19 US claimed
CN-114223080-A Electrolyte solution, electrochemical device, and electronic device 宁德新能源科技有限公司 2022-03-22 CN claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220153690-A1 ELECTROLYTE, AND ELECTROCHEMICAL DEVICE AND ELECTRONIC DEVICE INCLUDING SAME KCNQ1, HCN2, KCNQ4 TDP1 2821/4885PLA2G2C 1953/4885
US-12240798-B2 Electrolyte, and electrochemical device and electronic device including same KCNQ1, HCN2, KCNQ4 TDP1 2821/4885PLA2G2C 1953/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.